期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Immunotherapy of Cancer—A Historical Note
1
作者 Istvan Berczi 《Journal of Cancer Therapy》 2014年第13期1186-1189,共4页
We examined the possibility that the anti-estrogens, tamoxifen (TX) and toremifen (TO) interacted?with the immune system. Indeed, both TX and TO stimulated cells mediated cytotoxicity reactions by various killer cells... We examined the possibility that the anti-estrogens, tamoxifen (TX) and toremifen (TO) interacted?with the immune system. Indeed, both TX and TO stimulated cells mediated cytotoxicity reactions by various killer cells: killer T (TK), natural killer (NK), lymphokine activated killer (LAK) cells. Both TX and TO inhibited the growth of tumors that express estrogen receptors. Thus these antiestrogens inhibited tumor growth and stimulated killer cells for cytotoxicty on such tumors. Therefore these agents were presumed to stimulate tumor immunity. We tested the P815 mouse mastcytoma with TK, LK, and TX or TO. A therapeutic effect was observed in both experiments. The SL2-5 murine lymphoma was tested with NK and TX cells or TO cells and successful immunotherapy was observed.?We digested human breast carcinomas and lung tumors with collagenase. The killer cells were separated from tumor cells on Ficoll gradients. TX and TO enhanced the cytotoxic effect of autologous killer cells on the corresponding tumor cells. This experiment indicates that the results obtained in animals are also valid for human malignant disease. 展开更多
关键词 murine tumors: p815 masocytoma SL2-5 Lymphoma Human Cancers: Breast CARCINOMAS and Lung CARCINOMAS Tamoxifen Toremiphen Thymus-Derived Lymphocytes KILLER T CELLS (TK Cells) Natural KILLER CELLS (NK Cells) Lymhokine Activated KILLER CELLS (LAK Cells) Combination IMMUNOTHERAPY of CANCER
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部